celecoxib has been researched along with Alveolar Bone Atrophy in 4 studies
Excerpt | Relevance | Reference |
---|---|---|
"Alveolar bone loss was evaluated morphometrically under a stereomicroscope." | 5.35 | The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis. ( Atilla, G; Baylas, H; Buduneli, E; Buduneli, N; Sorsa, T; Turkoglu, O; Vardar-Sengul, S; Wahlgren, J, 2008) |
"The aim of this study was to evaluate the effects of selective cyclooxygenase-2 inhibitor, celecoxib, and omega-3 fatty acid on serum levels of interleukin 1-beta (IL-1beta), osteocalcin (OC), and C-reactive protein (CRP) in experimental periodontitis." | 3.73 | Effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats. ( Atilla, G; Baylas, H; Buduneli, E; Buduneli, N; Kinane, DF; Lappin, D; Vardar-Sengül, S, 2006) |
"These data provide evidence that systemic therapy with celecoxib can modify the progression of experimentally induced periodontitis in rats." | 3.71 | Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. ( Holzhausen, M; Marcantonio Júnior, E; Nassar, PO; Rossa Júnior, C; Spolidório, DM; Spolidório, LC, 2002) |
"Alveolar bone loss was evaluated morphometrically under a stereomicroscope." | 1.35 | The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis. ( Atilla, G; Baylas, H; Buduneli, E; Buduneli, N; Sorsa, T; Turkoglu, O; Vardar-Sengul, S; Wahlgren, J, 2008) |
"Arachidonic acid metabolites have been implicated in development of periodontal disease, especially those derived from the cyclo-oxygenase (COX) pathway." | 1.35 | Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats. ( Caliari, MV; Duarte, ID; Francischi, JN; Maltos, KL; Pacheco, CM; Queiroz-Junior, CM, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vardar-Sengul, S | 2 |
Buduneli, E | 2 |
Turkoglu, O | 1 |
Buduneli, N | 2 |
Atilla, G | 2 |
Wahlgren, J | 1 |
Sorsa, T | 1 |
Baylas, H | 2 |
Queiroz-Junior, CM | 1 |
Pacheco, CM | 1 |
Maltos, KL | 1 |
Caliari, MV | 1 |
Duarte, ID | 1 |
Francischi, JN | 1 |
Holzhausen, M | 1 |
Rossa Júnior, C | 1 |
Marcantonio Júnior, E | 1 |
Nassar, PO | 1 |
Spolidório, DM | 1 |
Spolidório, LC | 1 |
Lappin, D | 1 |
Kinane, DF | 1 |
4 other studies available for celecoxib and Alveolar Bone Atrophy
Article | Year |
---|---|
The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
Topics: Alveolar Bone Loss; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Co | 2008 |
Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats.
Topics: Alveolar Bone Loss; Animals; Arachidonic Acid; Celecoxib; Cyclooxygenase Inhibitors; Disease Models, | 2009 |
Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inh | 2002 |
Effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats.
Topics: Alveolar Bone Loss; Animals; C-Reactive Protein; Celecoxib; Cyclooxygenase 2 Inhibitors; Endotoxins; | 2006 |